Nutra Pharma Corp. Acquires Patents And Licenses For Medical Test Kits

BOYNTON BEACH, Fla.--(BUSINESS WIRE)--Jan. 25, 2006--Nutra Pharma Corp. (OTCBB:NPHC), a biotechnology company that owns rights to intellectual property related to the development of drugs for HIV and Multiple Sclerosis, has announced that it has signed a definitive agreement with NanoLogix, Inc. (Pink Sheets:NNLX) that will allow Nutra Pharma to market and distribute diagnostic test kits designed for the rapid isolation and identification of infectious diseases such as Tuberculosis (TB) and Mycobacterium avium-intracellulare (MAI).

Back to news